Can your body get used to semaglutide — and does that reduce how well it works?

The myth: 'my body has got used to it, so it's stopped working'

This is a question our prescribers hear most weeks, and the short answer is that it depends entirely on what you mean by 'used to it'. The concern usually comes from one of two experiences: side effects that were noticeable early on have faded, or weight loss has slowed after a promising start. Both are real phenomena. Neither means semaglutide has become ineffective.

When side effects such as nausea, reflux or loose stools settle during the first few weeks at a new dose, that is your gut adapting to a slower rate of gastric emptying. The medicine is still slowing digestion. The discomfort simply becomes less prominent as your body recalibrates. This is exactly what the dose-escalation schedule is designed to allow, each step gives you a month to adjust before moving higher. The physiological effects semaglutide has on the body are not diminishing; your nervous system is simply becoming less alarmed by them.

The efficacy question is more nuanced, and it deserves a proper answer rather than reassurance alone.

Why weight loss slows, and what's actually happening

A plateau in weight loss after several months on semaglutide is one of the most misunderstood events in treatment. It feels like the medicine has stopped working. What is actually happening is that your body's own weight-defending mechanisms have kicked in.

When you lose a meaningful amount of weight, your body responds by lowering its resting energy expenditure and increasing hunger signals from hormones like ghrelin. This is not specific to semaglutide, it happens with any significant weight loss, and the STEP 1 trial (published in the New England Journal of Medicine) observed it in participants on semaglutide 2.4mg too. Participants lost an average of around 15% of body weight over 68 weeks, with the rate of loss naturally slowing in the later months as physiology compensated.

So the plateau is your body's counter-regulation meeting semaglutide's appetite suppression somewhere in the middle. The medicine is still doing its job. The question is whether the dose is still the right one for where you are now, which is a clinical conversation, not a reason to stop.

For people curious about how the body's own GLP-1 compares to the synthetic version, that distinction also sheds light on why pharmaceutical semaglutide produces effects the body cannot replicate on its own.

Does true pharmacological tolerance develop with semaglutide?

Pharmacological tolerance (where receptors downregulate so that the same dose produces progressively less biological effect) is not a well-documented feature of GLP-1 receptor agonists like semaglutide. The mechanism is different from, say, stimulants or opioids, where receptor desensitisation is a recognised clinical problem.

The NHS notes that semaglutide works by mimicking the GLP-1 hormone, slowing gastric emptying and signalling fullness to the brain, and that these effects are maintained during treatment for the great majority of people. If you can find a clearer overview of what semaglutide is actually licensed to treat, it helps set realistic expectations from the outset.

That said, individual responses do vary. A small number of people report that a given dose feels less effective after many months. In that context, a prescriber would review whether a dose increase is clinically appropriate, whether lifestyle factors have shifted, or whether something else is contributing. The answer is not to assume the medicine has run its course.

For a broader picture of how Wegovy specifically compares across different situations, the Wegovy information page covers the licensed UK indications and what treatment involves in practice. And if you are weighing up the cost of ongoing treatment, a transparent look at Wegovy pricing in the UK is worth reading before making any decisions. Starting with a free consultation is the right first step if you have not yet spoken to a prescriber about your options.

What to do if you feel your response has changed

If weight loss has stalled and you have been on your current dose for more than three months, the most useful thing you can do is speak to your prescriber, not stop treatment, not switch without clinical input, and not interpret a plateau as failure.

A clinical review can establish whether you are at your highest tolerated dose, whether a structured adjustment to diet or activity might help, or whether the plateau reflects a degree of weight loss that is itself a meaningful health gain. The NHS guidance on semaglutide is clear that treatment decisions, including any changes to dose or duration, should be made with a healthcare professional, not independently.

Side effects that have not settled, or any new and unexpected symptoms, are always worth flagging promptly. Our guide to physical symptoms during Wegovy treatment covers what is typically transient and what warrants earlier contact. At nume, aftercare support is available seven days a week, if something feels off, you should be able to ask.